What is Royalty Pharma's lease liability payments - due year four?

Royalty Pharma (RPRX) reported lease liability payments - due year four of $3.76M in Q1 2026.

What does lease liability payments - due year four mean?

The total lease payments due in the fourth year from now.

Discontinued — last reported Q2 '20

Lease Liability Payments - Due Year Four

Royalty Pharma Lease Liability Payments - Due Year Four increased by 0.8% to $3.76M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement

SectionCurrent Liabilities

CategoryEfficiency

SignalLower is better

VolatilityStable

First reportedQ4 2019

Last reportedQ2 2020

How to read this metric

Consistent growth in these payments may indicate expansion of physical footprint or equipment fleet.

Detailed definition

The projected cash payments for operating and finance leases scheduled for the fourth year following the balance sheet d...

Peer comparison

Standard disclosure for lease maturity profiles.

Metric ID: lease_liability_payments_due_year_4

Historical Data

3 periods

	Q2 '25	Q3 '25	Q1 '26
Value	$3.73M	$3.73M	$3.76M
QoQ Change	—	+0.0%	+0.8%

Range$3.73M – $3.76M

Current Streak2+ quarters growth

Frequently Asked Questions

What is Royalty Pharma's lease liability payments - due year four?: Royalty Pharma (RPRX) reported lease liability payments - due year four of $3.76M in Q1 2026.
What does lease liability payments - due year four mean?: The total lease payments due in the fourth year from now.